Release Date: 05/05/10 16:56 Summary: Response to ASX Appendix 5B Query Price Sensitive: Yes Download Document 63.2KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%